Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors Journal Article uri icon

Overview

publication date

  • September 1, 2020

has subject area

has restriction

  • bronze

Date in CU Experts

  • May 19, 2020 11:12 AM

Full Author List

  • Davis SL; Ionkina AA; Bagby SM; Orth JD; Gittleman B; Marcus JM; Lam ET; Corr BR; O'Bryant CL; Glode AE

author count

  • 21

citation count

  • 6

Other Profiles

International Standard Serial Number (ISSN)

  • 1078-0432

Electronic International Standard Serial Number (EISSN)

  • 1557-3265

Additional Document Info

start page

  • 4633

end page

  • 4642

volume

  • 26

issue

  • 17